Patents for C07D 263 - Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings (20,978) |
---|
01/20/2010 | EP1513818B1 Heterocyclic inhibitors of vegfr-2 kinases |
01/19/2010 | US7649005 Substituted benzylaminoalkylene heterocycles |
01/19/2010 | US7648999 Activator for peroxisome proliferator-activated receptor δ |
01/19/2010 | CA2413000C Five-membered ring compounds |
01/19/2010 | CA2143135C Process for sulfinylating heterocyclic compounds |
01/14/2010 | WO2010004228A2 Novel discriminating molecule family for neutron and gamma radiation |
01/14/2010 | WO2009140932A3 Method of producing (3r,4s)-l-(4-fluorophenyl)-3-[(3s)-3-(4-fluorophenyl)- hydroxypropyl)]-4-(4-hydroxyphenyl)-2-azetidinone |
01/14/2010 | US20100010232 Aryl derivatives of curcumin, demethoxycurcumin, bisdemethoxycurcumin or curcuminisoxazolide and their use as animal feed additives |
01/14/2010 | US20100010227 Process for production of piperidine derivatives |
01/14/2010 | US20100010063 Heterocyclocarboxamide derivatives |
01/14/2010 | US20100010060 Isoindolin-1-One-, Isoindolin-3-One- and Isoindolin-1,3-Dione-Derivatives and Use Thereof |
01/14/2010 | US20100009991 Polycyclic acid compounds useful as crth2 antagonists and antiallergic agents |
01/14/2010 | US20100009978 Benzoxazoles and Oxazolopyridines Being Useful as Janus Kinases Inhibitors |
01/14/2010 | CA2730377A1 Tetracycline derivatives with reduced antibiotic activity and neuroprotective benefits |
01/13/2010 | EP1575911B1 Biaromatic compounds which activate ppar-gamma type receptors and use thereof in cosmetic or pharmaceutical compositions |
01/13/2010 | CN101627021A Prophylactic and/or therapeutic agent for hyperlipemia |
01/12/2010 | US7645798 N-(2-hydroxyalkanoyl)-N,N′-dialkylureas and a process for their preparation |
01/12/2010 | US7645781 N-aryl-2-oxazolidinone-5-carboxamides and their derivatives |
01/12/2010 | US7645779 Linked biaryl compounds |
01/12/2010 | US7645757 Derivatives of heteroaryl-alkylcarbamates, methods for their preparation and use thereof as fatty acid amido hydrolase enzyme inhibitors |
01/12/2010 | US7645751 Mandelic acid derivatives and their use as thrombin inhibitors |
01/12/2010 | CA2407463C N-substituted peptidyl nitriles as cysteine cathepsin inhibitors |
01/12/2010 | CA2375834C Process for making taxane derivatives |
01/12/2010 | CA2192089C Inhibitors of interleukin-1.beta. converting enzyme |
01/07/2010 | WO2010002209A2 Novel compounds, isomer thereof, or pharmaceutically acceptable salts thereof as vanilloid receptor antagonist and pharmaceutical compositions containing the same |
01/07/2010 | WO2009000533A8 Novel herbicides |
01/07/2010 | US20100004301 Benzoxazoles Useful in the Treatment of Inflammation |
01/07/2010 | US20100004298 P-38 inhibitors |
01/07/2010 | US20100004297 Novel hexafluoroisopropanol derivatives |
01/07/2010 | US20100004292 Iminooxazolidine Derivatives and Their Use |
01/07/2010 | US20100004277 Compounds and methods for modulating protein trafficking |
01/07/2010 | US20100004271 Heterocyclic compounds as aganist for the thyroid receptor |
01/07/2010 | US20100003445 Cyanine compound and optical filter and optical recording material containing same |
01/06/2010 | EP2141155A1 Prophylactic and/or therapeutic agent for hyperlipemia |
01/06/2010 | EP2141154A1 Oxazolidinone derivative having inhibitory activity on 11 -hydroxysteroid dehydrogenase type i |
01/06/2010 | EP2140865A1 Thiazoles and oxazoles useful as modulators of atp-binding cassette transporters |
01/06/2010 | EP2139875A2 Oxazolidine and morpholine carboxamide derivatives as p2x7 modulators |
01/05/2010 | US7642358 Antidiabetic agents; modulate insulin drug resistance |
01/05/2010 | US7642303 Thermoplastic articles for packaging UV sensitive materials, processes for the articles production and use and novel UV absorbers |
01/05/2010 | CA2318192C .beta.2-adrenergic receptor agonists |
12/31/2009 | US20090326020 Compounds for treatment of cancer |
12/31/2009 | US20090325962 Tyrosine derivative |
12/31/2009 | US20090325944 Methods and Compositions for Modulating Glycosylation |
12/30/2009 | WO2009157019A2 Process for preparing ezetimibe using novel allyl intermediates |
12/30/2009 | EP2136637A1 Inhibitors of cholesterol ester transfer protein |
12/30/2009 | EP1613587B1 Organic compounds |
12/30/2009 | EP1501812B1 Pna monomer and precursor |
12/30/2009 | CN101616902A 2-aminooxazolines as TAAR1 ligands |
12/30/2009 | CN100575348C Synthesis of amino acid, n-carboxyanhydrides |
12/30/2009 | CA2729227A1 2-heterocyclylaminoalkyl-(p-quinone) derivatives for treatment of oxidative stress diseases |
12/29/2009 | US7638648 Compounds having selective cytochrome P450RAI-1 or selective cytochrome P450RAI-2 inhibitory activity and methods of obtaining the same |
12/29/2009 | US7638637 Orally available sphingosine 1-phosphate receptor agonists and antagonists |
12/29/2009 | US7638513 inhibitors of matrix metalloproteinases, aggrecanases, tumor necrosis factor-alpha converting enzyme, and tumor necrosis factors |
12/29/2009 | CA2370250C Di-aryl acid derivatives as ppar receptor ligands |
12/24/2009 | US20090318514 Novel Pharmaceutical Compositions |
12/24/2009 | US20090318445 Pdf inhibitors |
12/23/2009 | WO2009154785A2 C4-substituted alpha-keto oxazoles |
12/23/2009 | WO2009153238A1 Aminothiazoline compounds for combating insects, arachnids and nematodes |
12/23/2009 | WO2009066060A3 4-substituted-6-isopropyl-benzene-1,3-diol compounds and their use |
12/23/2009 | EP2134697A2 Separation and manipulation of a chiral object |
12/23/2009 | EP1879564B1 Compounds to treat amyloidosis and prevent death of beta-cells in type 2 diabetes mellitus |
12/23/2009 | CN100572367C 1-(azolin-2-yl)amino-1,2-diphenylethane compounds for combatting insects, arachnids and nematodes |
12/23/2009 | CN100572348C Process for preparing the enantiomeric forms of cis-configured 1,3-cyclohexanediol derivatives |
12/22/2009 | US7635708 Peroxidase proliferator activated receptor (PPAR) gamma agonists for playing key role in inducing growth arrest by terminal differentiation of actively proliferating PPAR gamma-expressing cells, particularly transformed adipose cells |
12/22/2009 | CA2558908C 10-deacetylbaccatine iii and 10-deacetyl 14.beta.-hydroxybaccatine iii derivatives and intermediates useful in the preparation thereof |
12/22/2009 | CA2290744C Cyclic diamine compounds and medicine containing the same |
12/17/2009 | WO2009149508A1 Novel potassium channel blockers and uses thereof |
12/17/2009 | WO2008109727A8 Substituted phenoxy thiazolidinediones as estrogen related receptor-alpha modulators |
12/17/2009 | US20090312365 Certain Chemical Entities, Compositions, and Methods |
12/17/2009 | US20090312363 Bifunctional histone deacetylase inhibitors |
12/17/2009 | US20090312303 Antidiabetic Bicyclic Compounds |
12/17/2009 | US20090311266 Inhibitors of the endothelin signalling pathway and alphavbeta3 integrin receptor antagonists for combination therapy |
12/17/2009 | CA2727780A1 Novel potassium channel blockers and uses thereof |
12/16/2009 | EP2133342A1 Protein tyrosine phosphatase 1b inhibitor, preparation methods and uses thereof |
12/16/2009 | CN101602740A Method for extracting epigoitrin from isatis root with high extraction ratio |
12/16/2009 | CN100569729C Method for producing optically active cyclopropanecarboxylate compound |
12/15/2009 | US7632928 4-oxo-pent-2-enenitrile derivative of a nitrofuran conjugated to a bifunctional cross-linker alone, a bifunctional cross-linker conjugated further to a protein carrier, a peptide conjugated to a protein carrier, and a protein, a nucleic acid, a polysaccharide; antibody and immunogen |
12/15/2009 | US7632865 N-(4-(3-chloro-5-trifluoromethyl-2-pyridyloxy)phenyl)-2-chloro-5-nitrothiobenzamide, for example; useful as preventive or therapeutic medicines for diseases accompanied by hyperactivated immune functions |
12/15/2009 | US7632850 2-amino-2-oxoethyl 1-(4'-fluoro-1,1'-biphenyl-4-yl)cyclopropylmethylcarbamate and 2-(methylamino)-2-oxoethyl 1-(4'-fluoro-1,1'-biphenyl-4-yl)cyclopropylmethylcarbamate; fatty acid amide (FAAH) hyrdrolase inhibitors; analgesics; neuropathic pain;psychological disorders; anticarcinogenic agents; AIDS |
12/15/2009 | CA2342217C Process for producing stereoselective nitro compounds |
12/10/2009 | WO2009101082A9 Substituted sulfonic acid amide compounds |
12/10/2009 | WO2009015369A3 Isophthalamide derivatives inhibiting beta-secretase activity |
12/10/2009 | US20090306389 Intermediate products for producing oxazolidinone-quinolone hybrids |
12/10/2009 | US20090306127 Certain Chemical Entities, Compositions and Methods |
12/10/2009 | US20090306078 Compounds that inhibit hif-1 activity, the method for preparation thereof and the pharmaceutical composition containing them as an effective component |
12/09/2009 | EP2130820A1 Antipruritics |
12/09/2009 | EP2129668A1 Substituted phenoxy thiazolidinediones as estrogen related receptor-alpha modulators |
12/09/2009 | EP2129654A1 Novel antagonists of the glucagon receptor |
12/09/2009 | EP1435964B1 Novel prodrugs of n-h bond-containing compounds and methods of making thereof |
12/09/2009 | EP1409450B1 N-(3-amino-2-hydroxy-propyl) substituted alkylamide compounds |
12/09/2009 | EP1300401B1 Thiazole derivatives for use as antiinflammatories |
12/09/2009 | EP1067109B1 Carboxylic acid derivatives and drugs containing the same as the active ingredient |
12/09/2009 | CN101600700A Novel 2-aminooxazolines as TAAR1 ligands for CNS disorders |
12/09/2009 | CN101600689A Compounds and compositions as inhibitors of cannabinoid receptor 1 activity |
12/09/2009 | CN100567277C Production of N-containing pentabasic heteroaromatic formamidine and salts thereof |
12/09/2009 | CN100567273C Organic compounds |
12/09/2009 | CN100567265C Organometallic complexes and organic electroluminescence device using the same |
12/08/2009 | US7629467 Diphenyl substituted cycloalkanes, compositions containing such compounds and methods of use |
12/08/2009 | CA2404725C Extrusion die |
12/03/2009 | US20090298854 Indole acetic acid derivatives and their use as pharmaceutical agents |